Brainstorm Cell Therapeutics (BCLI) Long-Term Investments (2009 - 2015)
Brainstorm Cell Therapeutics (BCLI) recorded Long-Term Investments of $20,000 in Q2 2015, up 33.3% from $15,000 a year earlier and up 5.3% from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Long-Term Investments (2009 - 2015) Analysis & Trends
Starting with Q4 2010, Brainstorm Cell Therapeutics' Long-Term Investments history includes 18 quarters.
- Annual Long-Term Investments has a four-year compound annual growth rate of -31.5% (FY2010 to FY2014).
- Across earlier years, Long-Term Investments came in at $22,000 in FY2013 (+29.4%), $17,000 in FY2012 (-86.5%), $126,000 in FY2011 (+38.5%) and $91,000 in FY2010.
- Quarterly Long-Term Investments has ranged from $13,000 in Q1 2014 to $273,000 in Q3 2013 over the past five years.
- On a year-over-year basis, Long-Term Investments rose in four of the last eight quarters, with an average decline of 14.1%.
- Peak year-over-year performance for Long-Term Investments in the last five years was growth of 67.5% in Q3 2013, against a decline of 94.0% in Q1 2014 at the low end.
- Per Business Quant, the preceding three quarters came in at $19,000 (Q1 2015), $20,000 (Q4 2014) and $21,000 (Q3 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.01 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 387.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.60 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 63.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 268.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.45 Bn |
| 10 | Brainstorm Cell Therapeutics | 10.92 Mn | 10.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | 20,000.00 |
| Mar 31, 2015 | 19,000.00 |
| Dec 31, 2014 | 20,000.00 |
| Sep 30, 2014 | 21,000.00 |
| Jun 30, 2014 | 15,000.00 |
| Mar 31, 2014 | 13,000.00 |
| Dec 31, 2013 | 22,000.00 |
| Sep 30, 2013 | 273,000.00 |
| Jun 30, 2013 | 241,000.00 |
| Mar 31, 2013 | 218,000.00 |
| Dec 31, 2012 | 17,000.00 |
| Sep 30, 2012 | 163,000.00 |
| Jun 30, 2012 | 151,000.00 |
| Mar 31, 2012 | 146,000.00 |
| Dec 31, 2011 | 126,000.00 |
| Sep 30, 2011 | 107,000.00 |
| Jun 30, 2011 | 103,000.00 |
| Mar 31, 2011 | 100,000.00 |
| Dec 31, 2010 | 91,000.00 |
| Sep 30, 2010 | 62,000.00 |
API Access
Brainstorm Cell Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();